Summary. 6-Hydroxydopamine, when injected at 14:00 h on Days 21 and 22 of pregnancy in the rat (2 \m=x\50 mg/kg), markedly decreased plasma and uterine noradrenaline concentrations ( \m=-\60% and \m=-\82% respectively; P < 0\m=.\001). As a consequence of this treatment, there was severe disturbance in the distribution pattern of parturitions: 61% of rats had suppressed parturition and 31% of rats displayed a lengthened or interrupted labour. A bolus dose of prazosin (3 mg/kg) administered at 12:00 h on Day 22 completely blocked the normal process of parturition throughout the next 6 h, a result which is compatible with the half-life of the drug (2\m=.\9\ m=+-\ 0\m=.\8 h). Administration of phentolamine (3 mg/kg) at term induced a significant decrease of uterine activity (frequency \m=x\duration of bursts of spike potentials) as revealed by electromyographic recordings in vivo. These results suggest that noradrenaline released from sympathetic nerve terminals interacts with \g=a\-adrenoceptors located post-synaptically to improve the overall excitability of the myometrium at the onset of labour.
Introduction
Before delivery, the electrical activity of the rat myometrium, measured in vitro (Bengtsson, Chow & Marshall, 1984) or in vivo (Legrand & Maltier, 1981a) , is greatly enhanced. This change is neces¬ sary for normal parturition, because if it does not occur delivery is abnormal or delayed (Anderson, Kawarabayashi & Marshall, 1981; Legrand 8c Maltier, 1981a) .
In vitro, it has been widely reported that catecholamines modify the electrical and mechanical responses of smooth muscle from pregnant rat uteri (Abdel-Aziz & Bakry, 1973; Kawarabayashi & Osa, 1976; Osa & Watanabe, 1978; Chow & Marshall, 1981) . One objective of the present study was to determine whether the noradrenergic transmission via action on post-synaptic a-adrenoceptors of the myometrium is a physiological regulatory mechanism of parturition in the rat. / In the uterus of the late pregnant rat, noradrenaline is the major catecholamine (Arkinstall & Jones, 1985) and 80% originates from the sympathetic nerves that innervate smooth muscle cells (J. P. Maltier & C. Legrand, unpublished results) . Although the uterine concentration of noradrenaline is reduced in the last third of pregnancy in the rat, a result which is in agreement with previous reports on uteri of pregnant rabbits, guinea-pigs and women (Thorbert, 1979; Thorbert, Alm, Björklund, Owman & Sjöberg, 1979; Arkinstall & Jones, 1985) , adequate methods for analysis of the turn-over rate of the neurotransmitter indicate that it is greatly enhanced just before delivery (J. P. Maltier & C. Legrand, unpublished results) . This observation is a reliable index of neuronal activity in the rat uterus at term. On the basis of such a consideration, we suspect that noradrenergic transmission is maintained in the late pregnant rat myometrium despite severe reduction in tissue levels of noradrenaline. Maltier, Legrand & Corazza (1984) have postulated that an excitatory effect of noradrenaline, mediated via the myometrial a-adrenoceptors, is probably implicated in uterine contractility of parturient rats because a significant increase ( + 65%) of the ^-receptor concentration is observed at parturition. /
The present experiments were designed to determine the effects of 6-hydroxydopamine, phentolamine or prazosin treatment on parturition in rats to investigate the role of uterine noradrenergic transmission. The neurotoxin 6-hydroxydopamine has been shown to produce a long-lasting depletion of noradrenaline from various peripheral organs and a functional failure of transmission at sympathetic nerve ends (Malmfors & Sachs, 1968; Thoenen & Tranzer, 1968; Jonsson & Sachs, 1970; De Champlain & Nadeau, 1971) . Phentolamine is a selective antagonist of a-adrenoceptors (Ruffolo, 1984) and prazosin is a powerful post-synaptic a-adrenergic blocking agent (Cambridge, Davey & Massingham, 1977; Doxley, Smith & Walker, 1977; Caverò & Roach, 1980; Ruffolo, 1984 Recordings were started on Day 21 of pregnancy. The overall operative procedure had no deleterious effect upon pregnancy and all the rats littered normally between 12:00 h on Day 22 and 12:00 h on Day 23 which is the normal range for parturitions in our breeding colony. During all recording sessions, animals were allowed to move freely in their cage and received water and food ad libitum. Three types of experimental animals were used: 9 females were left untreated after surgi¬ cal procedures to detect normal activity of the myometrium; 4 rats were injected intraperitoneally at the time of vaginal bleeding with a bolus dose of 1 mg phentolamine (2-([yV-(m-hydroxyphenyl)-/?-toluidino]-methyl)-2-imidazoline methane sulphonate; Ciba-Geigy, Basle, Switzerland) dissolved in 1 ml 0-9% (w/v) NaCl; and 4 rats were treated with 1 ml saline and served as controls for the phentolamine-injected animals.
All females allowed to litter normally (Groups 1A, IB, 2A, 2B and 3) were autopsied after 12:00 h on Day 23 to determine whether parturitions were complete or partial.
Assay methods for noradrenaline Peripheral blood was collected into heparinized flasks and centrifuged at 5000 g for 5 min at 0-4cC. Then, plasma was mixed (v/v) with ice-cold 0-6 N-perchloric acid. After mixing, the acidified plasma was centrifuged at 4°C for 5 min at 27000 g and the supernatant fraction was taken for noradrenaline assay. Immediately after blood collection, uteri were isolated, defatted, weighed and homogenized in 10 volumes (w/v) ice-cold 0-3 M-perchloric acid with 01% ascorbic acid with an Ultra-Turrax homogenizer. The homogenate was centrifuged at 4°C for 5 min at 27 000 g. The supematants were frozen and stored in liquid nitrogen before noradrenaline assay.
Plasma and uterine noradrenaline were assayed by the radioenzymic procedure of Da Prada & Zürcher (1976 (Snedecor & Cochran, 1957) .
Results
Noradrenaline concentrations in plasma and uterine tissues in 6-0HD -treatedfats By 2 h after the second injection of 6-OHDA (16:00 h on Day 22) plasma and uterine noradrenaline concentrations were greatly depleted (Fig. 1) . Plasma noradrenaline was 8-2+1-0pg/ml compared with 22-2 + 21 pg/ml in control rats ( < 0001). Uterine noradrenaline was 1-3 + 0-4 ng/g compared with 7-4 ± 1-4 ng/g in controls (reduction of 82%, < 0001).
Delivery patterns in normal and treated rats Untreated rats. The events of labour were recorded by continuous observation. The delivery of the first young was considered as the onset of parturition. The duration of parturition was estimated as the time from the delivery of the first to the last young of a litter. (Fig. 2) .
Duration of delivery was 94+10 min in the group of untreated rats (Group 3). When duration of parturition exceeded 2 h delivery was considered abnormal.
6-OHDA-treated rats. Immediately after the first injection of 6-OHDA, the rats showed tran¬ sient signs of sympathomimetic stimulation (e.g. hair erection) which was much less pronounced after the second dose.
The distribution of parturitions in 6-OHDA-treated rats (Group 1A) is presented in Fig. 3 Fig. 5 . Short bursts of spike potentials occurred irregularly and there was no precise relationship between the activity recorded at each end of the uterus. At parturition, electrical bursts were more synchronized and their duration, frequency and amplitude were increased (Fig. 5) .
As illustrated in Fig. 6 , three major phases could be distinguished in the changes of uterine activity that occurred during the last 36 h before delivery. Up to 16 h before birth the activity remained fairly stable. Then, the activity increased progressively during the next 10 h. During the last 6 h of pregnancy there was a sharp increase of activity which culminated when the first young was expelled. A similar evolution of electrical activity was seen at the cervical and ovarian ends of uterine horns (Table 1 ). The amplitude of the spike potentials was increased progressively in the last 10 h before birth, with a marked increase at the cervical end of the uterus (Table 1 ). Injections (s.c.) of 1 mg phentolamine at the time of vaginal bleeding produced in the next 30 min a significant inhibition of the duration of the uterine activity (P < 0001) which was not observed after vehicle administration (Fig. 6) . The amplitude of the spike potentials measured at the cervical end of the uterus was unaffected by the drug administration: it remained at 249 + 23 µ 10 min after treatment and was successively 241 + 79, 268 ± 76, 234 + 50 and 234 + 68 µ in the next 20,40, 50 and 60 min.
Discussion
The results presented in this paper disclose a rapid and drastic reduction of endogenous noradrenaline concentrations in both plasma and uterus produced by 6-OHDA (respectively -60% and -82%). This treatment (2 50 mg/kg, 24-h interval) was chosen to obtain a con¬ sistent long-lasting disappearance of endogenous noradrenaline (Thoenen & Tranzer, 1968) . The noradrenaline depletion caused by 6-OHDA could be due to a selective destruction of the noradrenergic nerve terminals (Tranzer & Thoenen, 1967; Malmfors & Sachs, 1968) . According to Jonsson & Sachs (1970) 6-OHDA may act as a 'false neurotransmitter' which displaces noradrenaline from its binding sites (Thoenen & Tranzer, 1968) . Whatever the precise mechanism of action of 6-OHDA, the drug produces an effective sympathectomy. This result is in agreement with previous data of Thorbert, Alm, Owman, Rosengren & Sjöberg (1978) on the cyclic guinea-pig uterus. The very marked disturbance in the distribution of the moment of parturition that we found could be considered a consequence of the treatment: only 8% of rats had completely normal delivery, 61% of the remaining rats had entirely suppressed parturitions, the other rats presenting partial or lengthened deliveries. Our results with adrenoceptor blocking agents (prazosin or phentolamine) provide indirect evidence that the normal process of delivery is probably related to the subsequent interaction of the noradrenaline with -excitatory adrenoceptor sites in the myometrium. The characteristics of a-adrenoceptors present on the cell surface of preparturient rat myometrium have been reported by Maltier et al. (1984) ./ The numbers of myometrial aadrenoceptors, which mediate uterine contractions, are increased in the last 6 h of pregnancy (Maltier et al., 1984) , a time when the activity of the uterus (EMG recordings in vivo) appears greatly enhanced. Prazosin, a powerful a!-adrenoceptor antagonist (Ruffolo, 1984) , selectively blocks post-junctional excitatory oij-adrenoceptors, without acting upon the pre-junctional a2-adrenoceptors which regulate the noradrenaline release via a negative feed-back mechanism (Cambridge et al., 1977; Caverò & Roach, 1980; Kobinger, 1984) Bosc & Nicolle (1979) , the injection of vehicle applied just before the onset of labour is a stress which delayed the time of birth of the first youngJThe effect of the stress induced by vehicle-injection can be attributed to the changes of catecholamine levels (Legrand & Maltier, 1981b) and/or to the decrease of myometrial o^-adrenoceptors density, both factors regulating uterine activity. The hypothesis concerning the involvement of a noradrenergic transmission in the control of myometrial function at term was investigated by in-vivo recordings of myometrial activity in rats injected with phentolamine. A Phentolamine, a non-selective a! + a2-adrenoceptors antagonist, interferes with the release of endogenous noradrenaline via a presynaptic (a2) mechanism but antagonizes the postsynaptic !-adrenoceptor mediated responses of the myometrium. As could be expected from earlier obser¬ vations of Russe & Marshall (1970) , phentolamine administered in preparturient rats produced marked EMG activity (culminating in vaginal bleeding) and a marked but transient fall in electrical activity.
/ Such an inhibition of spontaneous activity of the uterus after phentolamine has been reported for the rhesus monkey (Harbert & Spisso, 1981) . In these conditions it is possible that the sudden increase in EMG activity of the uterus 4-6 h before the expulsion of the first young may be elicited by -stimulatory noradrenergic transmission which then could intensify the uterine sensitivity to oxyjoçin (Russe 8c Marshall, 1970) and elicit strong uterine contraction (Bengtsson et al., 1984) .
